Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Genital Diseases, Male × onapristone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Urogenital Neoplasms 1 Prostatic Neoplasms 1 Prostatic Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Endometrial Neoplasms 1

Interventions

onapristone 1 gedatolisib 1 darolutamide 1 abiraterone 1 EPI-506 1 BAY 86-7548 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02049190 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Arno Therapeutics

Phase 1/2 Unknown

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡